Search

In the current work, a series of flexible polymer matrix composites (PMCs) based on poly(vinylidene fluoride‐hexafluoropropylene) (PVDF‐HFP) as the polymer matrix and carbon nanofillers, namely single‐walled nanotubes (SWCNT) or carbon blacks (CB), were fabricated via a facile preparation method of blending and solution casting. The electrical conductivity, morphology, dielectric constant, mechanics, and electromagnetic interference (EMI) shielding properties of the composite films were adjusted by varying the carbon type (CB = Ketjenblack, Vulcan, or SWCNT = Tuball) and amount (0.1–15 wt%). The influence of the conductive nanofillers on the EMI shielding effectiveness (SE) and microwave absorbing properties in the X‐band frequency range (8–12 GHz) were investigated. By increasing the carbon content, the EMI shielding properties of the composite films were improved due to an increase in the magnitude of the electromagnetic properties. As the loading of these carbon fillers approach the percolation threshold, the dielectric constant of the composite can dramatically increase because of the construction of a microcapacitor network. However, these nanofillers/polymer composites generally have high dielectric loss near the percolation threshold due to the direct connection between carbon nanofillers. The PVDF‐HFP/Tuball composite particularly contributed low dielectric loss to the electromagnetic (EM) wave, resulting in excellent microwave absorption properties with a SE per unit thickness of 337.5 dB/mm and 2.5× less weight compared with conventional aluminum with the same SE, demonstrating the promise of using these materials as practical EMI shields. [ABSTRACT FROM AUTHOR]

Different weight ratios of polyaniline (PANI) to poly (acrylic acid) (PAA) were synthesized as interpenetrating polymer networks and blended with sulfonated poly (ether ether ketone) (SPEEK). In‐situ polymerization was performed by chemical oxidation of aniline in the presence of PAA. The composites showed actuation capability in the presence of fuel/air and moisture. Mechanical testing indicated that samples with higher concentration of PAA were stronger. For instance, PANI1PAA2SPEEK3 breaks at 8.4 MPa and has a failure strain of 2.5%, which is higher than PANI3PAA1SPEEK3 at 7 MPa and 2%. However, higher amount of PAA resulted in a lower electrochemical conductivity of 1.52 × 10−2 S/cm for the former and 1.8 × 10−2 S/cm for the latter. Intermolecular interaction at the optimum composition is necessary to induce forward and reverse bending of catalyst coated composite under exposure of fuel and air. In addition, the formation of compact structures and rough surfaces resulted in the maximal contractile strain of 1% for PANI3PAA1SPEEK3 based on moisture actuation. [ABSTRACT FROM AUTHOR]

Human complement C4 is one of the most diverse but heritable effectors for humoral immunity. To help understand the roles of C4 in the defense and pathogenesis of autoimmune and inflammatory diseases, we determined the bases of polymorphisms including the frequent genetic deficiency of C4A and/or C4B isotypes. We demonstrated the diversities of C4A and C4B proteins and their gene copy number variations (CNVs) in healthy subjects and patients with autoimmune disease, such as type 1 diabetes, systemic lupus erythematosus (SLE) and encephalitis. We identified subjects with (a) the fastest migrating C4B allotype, B7, or (b) a deficiency of C4B protein caused by genetic mutation in addition to gene copy-number variation. Those variants and mutants were characterized, sequenced and specific techniques for detection developed. Novel findings were made in four case series. First, the amino acid sequence determinant for C4B7 was likely the R729Q variation at the anaphylatoxin-like region. Second, in healthy White subject MS630, a C-nucleotide deletion at codon-755 led to frameshift mutations in his single C4B gene, which was a private mutation. Third, in European family E94 with multiplex lupus-related mortality and low serum C4 levels, the culprit was a recurrent haplotype with HLA-A30, B18 and DR7 that segregated with two defective C4B genes and identical mutations at the donor splice site of intron-28. Fourth, in East-Asian subject E133P with anti-NMDA receptor encephalitis, the C4B gene had a mutation that changed tryptophan-660 to a stop-codon (W660x), which was present in a haplotype with HLA-DRB1*04:06 and B*15:27. The W660x mutation is recurrent among East-Asians with a frequency of 1.5% but not detectable among patients with SLE. A meticulous annotation of C4 sequences revealed clusters of variations proximal to sites for protein processing, activation and inactivation, and binding of interacting molecules. [ABSTRACT FROM AUTHOR]

A unique class of stimuli-responsive hydrogels, termed electroplastic elastomers (EPEs), whose mechanical properties can be reversibly tuned between hard and soft states with the application of an electric potential, is described. Electrochemically reversible cross-links formed within a permanent, covalently cross-linked polymeric hydrogel network are switched between strongly binding Fe3+ and weak to nonbinding Fe2+, as determined by potentiometric titration. With the incorporation of graphene oxide (GO) into the EPE, a significant enhancement in modulus and toughness was observed, allowing for the preparation of thinner EPE samples, 80-100 μm in thickness, which could be reversibly cycled between soft (Young's modulus: 0.38 MPa) and hard (2.3 MPa) states over 30 min. Further characterization of EPE samples by magnetic susceptibility measurements suggests the formation of multinuclear iron clusters within the gel [ABSTRACT FROM AUTHOR]

Abstract: Hydrolysis of acetylcholine by acetylcholinesterase (AChE) is extremely rapid, with a second-order hydrolysis rate constant k E (often denoted k cat/K M) that approaches 108 M−1 s−1. AChE contains a deep active site gorge with two sites of ligand binding, an acylation site (or A-site) containing the catalytic triad at the base of the gorge and a peripheral site (or P-site) near the gorge entrance. The P-site is known to contribute to catalytic efficiency with acetylthiocholine (AcSCh) by transiently trapping the substrate in a low affinity complex on its way to the A-site, where a short-lived acyl enzyme intermediate is produced. Here we ask whether the P-site does more than simply trap the substrate but in fact selectively gates entry to the A-site to provide specificity for AcSCh (and acetylcholine) relative to the close structural analogs acetyl(homo)thiocholine (Ac-hSCh, which adds one additional methylene group to thiocholine) and acetyl(nor)thiocholine (Ac-nSCh, which deletes one methylene group from thiocholine). We synthesized Ac-hSCh and Ac-nSCh and overcame technical difficulties associated with instability of the northiocholine hydrolysis product. We then compared the catalytic parameters of these substrates with AChE to those of AcSCh. Values of k E for Ac-hSCh and Ac-nSCh were about 2% of that for AcSCh. The k E for AcSCh is close to the theoretical diffusion-controlled limit for the substrate association rate constant, but k E values for Ac-hSCh or Ac-nSCh are too low to be limited by diffusion control. However, analyses of kinetic solvent isotope effects and inhibition patterns for P-site inhibitors indicate that these two analogs also do not equilibrate with the A-site prior to the initial acylation step of catalysis. We propose that k E for these substrates is partially rate-limited by a gating step that involves the movement of bound substrate from the P-site to the A-site. [Copyright &y& Elsevier]

Abstract: The limits of metal cation substitution and distribution in the sequence Bi2Fe4O9–Bi2Mn4O10 have been investigated by solid state synthesis, X-ray powder diffraction, and Mössbauer spectroscopy. Rietveld refinements conducted for the entire range along the join indicate the structures are orthorhombic with space group Pbam, with partial transition-metal site disorder confirmed and detailed by Mössbauer spectroscopy. Single-phase regions are found near each end-member and a two-phase region is observed at intermediate compositions, extending from about x=1 to 3, according to the general formula of the mixed crystals Bi2Fe4−x Mn x O10−δ . An incorporation of Mn at octahedral sites replacing Fe is taken into account for the Bi2Fe4O9-related side of the system. Charge compensation is believed to be effected by addition of O, which gives rise to the formation of FeO5 pyramids. At the Bi2Mn4O10-related side of the system, substitution of pyramidal Mn3+ by Fe3+ is envisaged. [Copyright &y& Elsevier]

Abstract: Acetylcholinesterase (AChE) contains a narrow and deep active site gorge with two sites of ligand binding, an acylation site (or A-site) at the base of the gorge and a peripheral site (or P-site) near the gorge entrance. The P-site contributes to the catalytic efficiency of substrate hydrolysis by transiently binding substrates on their way to the acylation site, where a short-lived acyl enzyme intermediate is produced. Ligands that bind to the A-site invariably inhibit the hydrolysis of all AChE substrates, but ligands that bind to the P-site inhibit the hydrolysis of some substrates but not others. To clarify the basis of this difference, we focus here on second-order rate constants for substrate hydrolysis (k E), a parameter that reflects the binding of ligands only to the free form of the enzyme and not to enzyme–substrate intermediates. We first describe an inhibitor competition assay that distinguishes whether a ligand is inhibiting AChE by binding to the A-site or the P-site. We then show that the P-site-specific ligand thioflavin T inhibits the hydrolysis of the rapidly hydrolyzed substrate acetylthiocholine but fails to show any inhibition of the slowly hydrolyzed substrates ATMA (3-(acetamido)-N,N,N-trimethylanilinium) and carbachol. We derive an expression for k E that accounts for these observations by recognizing that the rate-limiting steps for these substrates differ. The rate-limiting step for the slow substrates is the general base-catalyzed acylation reaction k 2, a step that is unaffected by bound thioflavin T. In contrast, the rate-limiting step for acetylthiocholine is either substrate association or substrate migration to the A-site, and these steps are blocked by bound thioflavin T. [ABSTRACT FROM AUTHOR]

Background Pediatric hematopoietic cell transplant (HCT) recipients often fail to have robust responses to influenza (flu) vaccine. We conducted a blinded phase II trial comparing high-dose (HD) trivalent inactivated vaccine (TIV) vs. standard dose (SD) quadrivalent inactivated vaccine (QIV). Methods Children 3–17 years old and 3–35 months post-allogeneic HCT were enrolled at 9 centers and randomized to either 2 doses of HD-TIV or SD-QIV during the 2016–2017 flu season. We compared immune responses by hemagglutination inhibition (HAI) from children 3–11 (early) vs. 12–35 (late) months (m) post-HCT to 3 common flu vaccine antigens, irrespective of vaccine type. HAI responses were evaluated at baseline (visit 1), 1 m post dose 1 (visit 2) and dose 2 (visit 3), and 7 m post dose 2 (visit 4). Geometric mean titers (GMT) were adjusted for baseline log-titer values. Results Thirty-one children, median age 11 (7–15) years, were enrolled; 17 (55%) were immunized early and 14 (45%) late. Over 50% of patients had a potentially seroprotective (≥1:40) HAI titer at baseline, with no significant difference post-vaccination between early and late subjects. Table 1 compares early vs late subjects with HAI seroconversion (4-fold HAI titer rise). Post dose 1, late subjects, compared with early, had higher rates of seroconversion to all influenza strains. Post dose 2, early subjects, compared with late, had increased seroconversion. Late subjects had higher GMTs for H1N1 post dose 1 and 2, H3N2 after dose 1, and strain B/VIC post dose 1 and 2 (Figure 1). Although immunogenicity waned throughout flu season, higher seroconversion rates and GMT to H3N2 and strain B/VIC were retained in late subjects. Conclusion Compared with subjects in early post-HCT group, late post-HCT subjects had better flu vaccine immune responses as noted by higher GMT and HAI seroconversion. However, 2 doses seemed more beneficial in the early post-HCT group. Future analyses are underway, including comparing immunogenicity of HD vs. SD flu vaccine. Disclosures Jennifer E. Schuster, MD, Satchel Health: Shareholder Flor M. Munoz, M.D, Biocryst: Grant/Research Support; CDC: Research Grant; Moderna: Other Financial or Material Support, Safety Monitoring Board Member/Chair; NIH: Research Grant; Novavax: Research Grant; UP to Date: Author and Editor - Royalties, Other Financial or Material Support. [ABSTRACT FROM AUTHOR]

Abstract: Impedance spectroscopy measurements, in the temperature range from room temperature to 600K, were performed in order to investigate the dielectric and ionic properties of Bi2Sn2O7 ceramics. The results show that the conductivity in this pyrochlore is associated with the hopping of ions. An activation energy of 1.26eV was observed and the dielectric constant exhibits a strong contribution from ionic conduction. [Copyright &y& Elsevier]

Highlights • Chemotherapy dose adjustment for obese patients is a common practice. • The adjustment factor varies across center practices. • Among patients with multiple myeloma and lymphoma, dose adjustment did not impact overall survival. Abstract Data are limited on whether to adjust high-dose chemotherapy before autologous hematopoietic cell transplant (autoHCT) in obese patients. This study explores the effects of dose adjustment on the outcomes of obese patients, defined as body mass index (BMI) ≥ 30 kg/m2. Dose adjustment was defined as a reduction in standard dosing ≥20%, based on ideal, reported dosing and actual weights. We included 2 groups of US patients who had received autoHCT between 2008 and 2014. Specifically, we included patients with multiple myeloma (MM, n = 1696) treated with high-dose melphalan and patients with Hodgkin or non-Hodgkin lymphomas (n = 781) who received carmustine, etoposide, cytarabine, and melphalan conditioning. Chemotherapy dose was adjusted in 1324 patients (78%) with MM and 608 patients (78%) with lymphoma. Age, sex, BMI, race, performance score, comorbidity index, and disease features (stage at diagnosis, disease status, and time to transplant) were similar between dose groups. In multivariate analyses for MM, adjusting for melphalan dose and for center effect had no impact on overall survival (P =.894) and treatment-related mortality (TRM) (P =.62), progression (P =.12), and progression-free survival (PFS; P =.178). In multivariate analyses for lymphoma, adjusting chemotherapy doses did not affect survival (P =.176), TRM (P =.802), relapse (P =.633), or PFS (P =.812). No center effect was observed in lymphoma. This study demonstrates that adjusting chemotherapy dose before autoHCT in obese patients with MM and lymphoma does not influence mortality. These results do not support adjusting chemotherapy dose in this population. [ABSTRACT FROM AUTHOR]

Abstract: The Bi2Sn2O7 pyrochlore is known to undergo a sequence of structural phase transitions with an increase in temperature. Raman spectroscopy was employed in the investigation of the temperature dependence of the active phonons in the Raman spectrum. We observed 19 broad modes at room temperature, reflecting the low symmetry of the α-phase of Bi2Sn2O7. The modes were discussed in relation to the Raman spectra of other pyrochlore-based oxides. The temperature dependence of the phonons evidences the α→β structural phase transition observed near 127°C. [Copyright &y& Elsevier]